Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study

BACKGROUND: Studies assessing the efficacy of pioglitazone solely for primary stroke prevention in Asian patients with type 2 diabetes mellitus (DM) and present multiple cardiovascular (CV) risk factors are rare. Thus, we aimed to assess the effect of pioglitazone on primary stroke prevention in Asi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Yi-Chih, Chiu, Lu-Ting, Huang, Hung-Yu, Bau, Da-Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306145/
https://www.ncbi.nlm.nih.gov/pubmed/32563247
http://dx.doi.org/10.1186/s12933-020-01056-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306145/
https://www.ncbi.nlm.nih.gov/pubmed/32563247
http://dx.doi.org/10.1186/s12933-020-01056-x

Ejemplares similares